Infusion

(redirected from continuous subcutaneous insulin infusion)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.
Related to continuous subcutaneous insulin infusion: insulin pump

INFUSION, med. jur. A pharmaceutical operation, which consists in pouring a hot or cold fluid upon a substance, whose medical properties it is desired to extract. Infusion is also used for the product of this operation. Although infusion differs from decoction, (q.v.) they are said to be ejusdem generis; and in the case of an indictment which charged the prisoner with giving a decoction, and the evidence was that he had given an infusion, the difference was held to be immaterial. 8 Camp. R. 74.

References in periodicals archive ?
Table 1: Glycemic and lipid assessment parameters from baseline to the end of study treatment with continuous subcutaneous insulin infusion (group A) or basal insulin glargine plus oral hyperglycemic agent (group B).
Howard et al., "A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes," Diabetes Care, vol.
Malfunction of continuous subcutaneous insulin infusion systems: a one-year prospective study of 127 patients.
Insulin pump for type 2 diabetes: use and misuse of continuous subcutaneous insulin infusion in type 2 diabetes.
Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.
Kim et al., "Improvement of cardiovascular risk factors in patients with type 2 diabetes after long-term continuous subcutaneous insulin infusion," Diabetes/Metabolism Research and Reviews, vol.
Indications and efficacy of continuous subcutaneous insulin infusion (CSII) therapy in Type 1 diabetes mellitus: a clinical audit in a specialist service.
The first continuous subcutaneous insulin infusion (CSII) system was developed in the 1960s, with commercial use beginning in 1978.
Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment.
In recent years, to reduce the complications and to improve blood glucose control, continuous subcutaneous insulin infusion (CSII) has been used as a popular option for diabetes management, especially in preschool-aged children (2,3).
Insulin Glulisine Compared to Insulin Aspart and to Insulin Lispro Administered by Continuous Subcutaneous Insulin Infusion in Patients with Type 1 Diabetes: A Randomized Controlled Trial.
Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Clin Ther 2009;31(5):980-987.

Full browser ?